Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Capricor Therapeutics Inc sell nvestor

Start price
€3.36
01.10.19 / 50%
Target price
€0.000
12.10.19
Performance (%)
-32.14%
End price
€2.28
12.10.19
Summary
This prediction ended on 12.10.19 with a price of €2.28. nvestor correctly predicted massive losses of -32.14% for Capricor Therapeutics Inc. nvestor has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Capricor Therapeutics Inc -16.071% -16.071% 21.290% 45.062%
iShares Core DAX® 1.804% -0.748% 13.168% 16.408%
iShares Nasdaq 100 -0.182% -3.412% 39.976% 43.502%
iShares Nikkei 225® 0.413% -7.381% 18.776% 2.874%
iShares S&P 500 0.664% -1.941% 28.141% 42.155%

According to nvestor what are the pros and cons of Capricor Therapeutics Inc for the foreseeable future?

Pros
Cons
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Low dividend yield expected
Little Investments for future growth
Risky balance sheet
Bad rating
ROE lower than 10% per year
Below average Management
Few uniques
Dependend from some customers or products
Sustainability is little important
Higher risks for its business
Below average Marketposition
Significant cyclical dependencies
Little known brand
Business model of the past or high risk
Probably not worthwhile Investment
Revenue decline/stagnation expected
negative Cash Flow expected
Increased challenges to pay loans and raise capital
Bad culture
Little innovation
high free float
Growths slower than the competition

Comments by nvestor for this prediction

In the thread Capricor Therapeutics Inc diskutieren

Sell mit Kursziel 0,0

Prediction Sell
Perf. (%) -32.14%
Target price 0.000
Change
Ends at 12.10.19

Sell beendet

Stopped prediction by nvestor for Capricor Therapeutics Inc

Capricor Therapeutics Inc

Start price
Target price
Perf. (%)
€3.32
30.09.23
€1.00
30.09.24
-17.17%
14.10.23

EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Low dividend yield expected
Capricor Therapeutics Inc

Start price
Target price
Perf. (%)
€7.10
25.07.20
€3.00
08.08.20
-29.86%
08.08.20

EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Low dividend yield expected